Adimmune Corp (4142) — Cash Flow Reinvestment Rate
Adimmune Corp (4142) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting NT$62.47 Million (capex NT$42.60 Million plus investments NT$19.87 Million) from operating cash flow of NT$658.32 Million. Explore Adimmune Corp capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Adimmune Corp Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Adimmune Corp across 6 annual periods. Also explore total assets of Adimmune Corp for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Adimmune Corp (2007–2024)
Year-by-year capital reinvestment analysis for Adimmune Corp. For live market cap and broader valuation context, see 4142 company net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | NT$256.18 Million | NT$668.48 Million | NT$155.22 Million | ▲ +72.2% |
| 2020 | 0.22x | NT$516.76 Million | NT$2.32 Billion | NT$218.30 Million | ▼ -99.6% |
| 2017 | 61.73x | NT$424.37 Million | NT$6.87 Million | NT$11.35 Million | ▲ +4990.1% |
| 2010 | 1.21x | NT$626.30 Million | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$703.82 Million | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$265.77 Million | NT$31.26 Million | NT$265.77 Million | — |